Home › Pulmonary Arterial Hypertension › Utah
Pulmonary Arterial Hypertension clinical trials in Utah
3 studies for Pulmonary Arterial Hypertension are looking for participants at sites in Utah.
Cities in Utah
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Intermountain Medical Center, Murray
- University of Utah Hospital, Salt Lake City
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06274801A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- The University of Utah, Salt Lake City
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 100 · All sexes · Updated Jul 21, 2026 · NCT06649110Pulmonary Hypertension Association Registry
- University of Utah Health, Salt Lake City
RecruitingObservational study
Ages 0 and older · All sexes · Updated Nov 14, 2025 · NCT04071327From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.